<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04076618</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00058279</org_study_id>
    <nct_id>NCT04076618</nct_id>
  </id_info>
  <brief_title>Incorporating Nutrition, Vests, Education, and Strength Training in Bone Health (INVEST in Bone Health)</brief_title>
  <acronym>INVEST</acronym>
  <official_title>Incorporating Nutrition, Vests, Education, and Strength Training in Bone Health (INVEST in Bone Health)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main goal of the proposed study is to compare the effects of weight loss (WL) alone with&#xD;
      WL plus weighted vest use or WL plus resistance exercise training (RT) on indicators of bone&#xD;
      health and subsequent fracture risk.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study team proposes that a 12 month trial in 192 older (60-85 years) adults with obesity&#xD;
      (Body mass index or BMI=30-40 kg/m2) randomized to one of three interventions (n=64/group):&#xD;
      WL alone (WL; caloric restriction targeting 10% WL); WL plus weighted vest use (WL+Vest);&#xD;
      targeting â‰¥8 hours/day, weight replacement titrated up to 10% WL); or, WL plus structured RT&#xD;
      (WL+RT; 3 days/week). Total hip trabecular volumetric bone mineral density (vBMD) is the&#xD;
      primary outcome. This outcome will be complemented by exploratory assessment of several&#xD;
      fracture-related risk factors, including: (1) femoral neck and lumbar spine vBMD, cortical&#xD;
      thickness, finite element modeling of bone strength, and regional fat and muscle volumes,&#xD;
      measured by CT; (2) areal bone mineral density (aBMD) at the total hip, femoral neck, lumbar&#xD;
      spine, and distal radius; trabecular bone score; and total body fat/lean masses, measured by&#xD;
      dual energy x-ray absorptiometry (DXA); (3) muscle function and strength; (4) biomarkers of&#xD;
      bone turnover; and (5) bone-regulating hormones/cytokines known to influence bone metabolism&#xD;
      during WL. Therefore, the investigators Specific Aims are to:&#xD;
&#xD;
      Aim 1: Determine the effects of WL+VEST compared to WL and WL+RT on 12 month change in total&#xD;
      hip trabecular vBMD. Despite similar reductions in total body weight, Hypothesis 1:&#xD;
      Participants in the WL+VEST group will show attenuated losses of total hip trabecular vBMD&#xD;
      versus WL; and Hypothesis 2: Loss in total hip trabecular vBMD will be no greater in WL+VEST&#xD;
      compared to WL+RT.&#xD;
&#xD;
      Aim 2: Explore the effects of WL+VEST compared to WL and WL+RT on the 12 month change in&#xD;
      fracture-related risk factors. Despite similar reductions in total body weight, we&#xD;
      hypothesize that WL+VEST and WL+RT will demonstrate improvements in fracture-related risk&#xD;
      factors compared to WL.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 12, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in total hip trabecular volumetric bone mineral density (vBMD)</measure>
    <time_frame>12 months from baseline</time_frame>
    <description>measurement taken during dual energy x-ray absorptiometry (DXA) scan</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">192</enrollment>
  <condition>Weight Loss</condition>
  <condition>Bone Health</condition>
  <arm_group>
    <arm_group_label>Weight Loss plus Vest</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Weight Loss Plus Resistance Exercise Training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Weight Loss</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vest</intervention_name>
    <description>Weighted Vest worn &gt; or = 8 hours per day</description>
    <arm_group_label>Weight Loss plus Vest</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Resistance Exercise Training</intervention_name>
    <description>Structured exercise training 3 days a week</description>
    <arm_group_label>Weight Loss Plus Resistance Exercise Training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>weight loss program</intervention_name>
    <description>a 24-week intensive phase (with weekly dietary classes) followed by a 27-week transition phase (with biweekly dietary classes)</description>
    <arm_group_label>Weight Loss</arm_group_label>
    <arm_group_label>Weight Loss Plus Resistance Exercise Training</arm_group_label>
    <arm_group_label>Weight Loss plus Vest</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 60-85 years&#xD;
&#xD;
          -  BMI=30-40 kg/m^2 or BMI 27.0-&lt;30.0 kg/m^2 plus one risk factor&#xD;
&#xD;
          -  Weight stability - no weight loss &gt; 5% in past 6 months&#xD;
&#xD;
          -  No contraindications for safe and optimal participation in exercise training/vest use.&#xD;
&#xD;
          -  Approved for participation by Study Coordinator&#xD;
&#xD;
          -  Willing to provide informed consent; agree to all study procedures and assessments;&#xD;
             Able to provide own transit to assessment/intervention visits&#xD;
&#xD;
          -  Willing to complete online/electronic study forms and participate in virtual group&#xD;
             sessions, as needed.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Weight greater than 450 lbs&#xD;
&#xD;
          -  Dependent on cane or walker: &gt;2 falls (injurious on non-injurious) in past year&#xD;
&#xD;
          -  Any contraindications for participation in voluntary weight loss&#xD;
&#xD;
          -  Smoker (&gt;1 cigarette/d or 4/wk within yr); Excessive alcohol use (&gt;14 drinks/wk)&#xD;
&#xD;
          -  Participation in regular resistance training and/or &gt; 20 mins/day of moderate&#xD;
             intensity aerobic exercise on &gt; 2 days/week in past 6 months&#xD;
&#xD;
          -  Osteoporosis (self-report and on prescription medication, T-score &lt; or = -2.5 on total&#xD;
             hip, femoral neck, lumbar spine or distal radius scan at screening visit, or FRAX&#xD;
             10-year risk scores &gt;3% for hip fracture or &gt;20% for major osteoporotic fracture (TBS&#xD;
             adjusted FRAX is preferable if available)&#xD;
&#xD;
          -  Self-reported prior spine, hip, wrist, or shoulder fracture after age 40 (except when&#xD;
             caused by trauma or fall from height)&#xD;
&#xD;
          -  Chronic back/shoulder/knee pain with current or past (within 1 year) prescription&#xD;
             medication use for at least 3 months&#xD;
&#xD;
          -  Severe, diagnosed arthritis (osteoarthritis, rheumatoid arthritis, or gout) with&#xD;
             current or past (within 1 year) prescription medication use for at least 3 months&#xD;
&#xD;
          -  Past (ever) or planned (next 12 months) back surgery&#xD;
&#xD;
          -  Past (6 months prior) or planned (next 12 months) joint replacement surgery; or past&#xD;
             (ever) bilateral hip replacement surgery&#xD;
&#xD;
          -  Uncontrolled hypertension (BP &gt; 160/90 mmHg)&#xD;
&#xD;
          -  Current or recent past (within 1 year) severe symptomatic heart disease, uncontrolled&#xD;
             angina, stroke, chronic respiratory disease requiring oxygen, neurological or&#xD;
             hematological disease requiring treatment for at least 3 months in past year&#xD;
&#xD;
          -  Cancer requiring treatment in past year, except non-melanoma skin cancer&#xD;
&#xD;
          -  Low Vitamin D (&lt;20 ng/mL)&#xD;
&#xD;
          -  Abnormal kidney or liver function (2x upper limits of normal)&#xD;
&#xD;
          -  eGFR&lt;45 mL/min/1.73m2,&#xD;
&#xD;
          -  Anemia (Hb &lt;13 g/dL in men/&lt;12 g/dL in women)&#xD;
&#xD;
          -  Uncontrolled diabetes (fasting glucose &gt; 140 mg/dL)&#xD;
&#xD;
          -  Regular use of: growth hormones, weight loss medications, oral steroids, insulin, or&#xD;
             prescription osteoporosis medications in the past year&#xD;
&#xD;
          -  No home computer, laptop or tablet with reliable home internet OR no smartphone&#xD;
             (touch-screen enabled phone) with reliable unlimited mobile internet&#xD;
&#xD;
          -  Involved in another behavioral/interventional research study, weight loss program, or&#xD;
             undergoing physical therapy.&#xD;
&#xD;
          -  Unable to tolerate diet, vest, or CT scan (claustrophobia)&#xD;
&#xD;
          -  Judged unsuitable for the trial for any reason by clinic staff&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristen Beavers, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Erica Lawrence</last_name>
    <phone>336-713-8531</phone>
    <email>erlawren@wakehealth.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Wake Forest University School of Medicine</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>August 29, 2019</study_first_submitted>
  <study_first_submitted_qc>August 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 3, 2019</study_first_posted>
  <last_update_submitted>March 15, 2021</last_update_submitted>
  <last_update_submitted_qc>March 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>nutrition</keyword>
  <keyword>vest</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

